Clinical trial
Modulation of Regional Brain Activation in Schizophrenic Patients by…
NCT00419653 · University of Jena, Other · Terminated
Key facts
| NCT number | NCT00419653 |
|---|---|
| Title | Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological Therapy |
| Official title | Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological Therapy With Amisulpride, Olanzapine or Haloperidol. A Study With Functional Magnetic Resonance Imaging (fMRI) and Diffusion Tensor Imaging (DTI) |
| Lead sponsor | University of Jena, Other |
| Collaborators | Sanofi Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Amisulpride, Olanzapine, Haloperidol |
| Enrollment | 19 |
| Start date | Jan 1, 2003 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Jan 9, 2007 |
| Last update posted | Sep 16, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: